Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
US Department of Justice
Cantor Fitzgerald
Medtronic
Citi
Baxter
Fuji
Accenture

Generated: June 18, 2018

DrugPatentWatch Database Preview

Retapamulin - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for retapamulin and what is the scope of retapamulin patent protection?

Retapamulin
is the generic ingredient in one branded drug marketed by Aqua Pharms Llc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Retapamulin has sixty-nine patent family members in thirty-five countries.

Three suppliers are listed for this compound.
Summary for retapamulin
International Patents:69
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 3
Bulk Api Vendors: 50
Clinical Trials: 16
Patent Applications: 411
DailyMed Link:retapamulin at DailyMed
Pharmacology for retapamulin
Synonyms for retapamulin
(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0;{1,8}]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetate
(3aS,4R,5S,6S,8R,9R,9aR,10R)-2-(exo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ylsulfanyl)acetic acid 5-hydroxy-4,6,9,10-tetraMethyl-1-oxo-6-vinylperhydro-3a,9-propanocyclopentacycloocten-8-yl ester (RETAPAMULIN)
(3as,4r,5s,6s,8r,9r,9ar,10r)-5-Hydroxy-4,6,9,10-Tetramethyl-1-Oxo-6-Vinyldecahydro-3a,9-Propanocyclopenta[8]annulen-8-Yl {[(3-Exo)-8-Methyl-8-Azabicyclo[3.2.1]oct-3-Yl]thio}acetate
224452-66-8
345632-67-9
452R668
4MG6O8991R
AB01566905_01
AK110479
AKOS016008865
AKOS030485971
Altabax
Altabax (Glaxo)
Altargo
AN-607
AS-11455
BC677692
C30H47NO4S
CR0022
CS-0618
DB01256
HY-17010
MFCD11045316
MolPort-006-167-754
MolPort-023-220-081
MP-0763
Retapamulin [USAN:INN:BAN]
retpamulin
RL02708
s4056
SB 275833
SB-275833
SB275833
SCHEMBL365459
ST24025747
UNII-4MG6O8991R
ZINC100013500
ZINC103660515
ZINC3931840

US Patents and Regulatory Information for retapamulin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms Llc ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Aqua Pharms Llc ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Aqua Pharms Llc ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for retapamulin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,281,226 Pleuromutilin derivatives as antimicrobials ➤ Try a Free Trial
RE39128 Pleuromutilin derivatives as antimicrobials ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for retapamulin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1028961/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009
C042/2007 Ireland ➤ Try a Free Trial SPC042/2007: 20080415, EXPIRES: 20220523
2007 00052 Denmark ➤ Try a Free Trial
6 Finland ➤ Try a Free Trial
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Merck
Teva
QuintilesIMS
US Department of Justice
Colorcon
Farmers Insurance
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.